Aaron Edward FOSTER

Person

Houston, TX, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods for inducing partial apoptosis using caspase polypeptides
- Patent number 11,839,647
- Issue date Dec 12, 2023
- Bellicum Pharmaceuticals, Inc.
- Kevin Slawin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified T cell comprising a polynucleotide encoding an inducible s...
- Patent number 10,934,346
- Issue date Mar 2, 2021
- Bellicum Pharmaceuticals, Inc.
- Aaron Edward Foster
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Costimulation of chimeric antigen receptors by MYD88 and CD40 polyp...
- Patent number 10,918,705
- Issue date Feb 16, 2021
- Bellicum Pharmaceutics, Inc.
- David Spencer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Costimulation of chimeric antigen receptors by MyD88 and CD40 polyp...
- Patent number 10,888,608
- Issue date Jan 12, 2021
- Bellicum Pharmaceuticals, Inc.
- David Spencer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for inducing partial apoptosis using caspase polypeptides
- Patent number 10,525,110
- Issue date Jan 7, 2020
- Bellicum Pharmaceuticals, Inc.
- Kevin Slawin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for controlling T cell proliferation
- Patent number 9,944,690
- Issue date Apr 17, 2018
- Bellicum Pharmaceuticals, Inc.
- David Spencer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for inducing partial apoptosis using caspase polypeptides
- Patent number 9,913,882
- Issue date Mar 13, 2018
- Bellicum Pharmaceuticals, Inc.
- Kevin Slawin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
- Publication number 20240368574
- Publication date Nov 7, 2024
- Board of Regents of the University of Texas System
- Joseph Henri Bayle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
- Publication number 20230065562
- Publication date Mar 2, 2023
- BELLICUM PHARMACEUTICALS, INC.
- Joseph Henri Bayle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS
- Publication number 20220152100
- Publication date May 19, 2022
- BELLICUM PHARMACEUTICALS, INC.
- David Michael Spencer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS
- Publication number 20220125837
- Publication date Apr 28, 2022
- BELLICUM PHARMACEUTICALS, INC.
- David M. Spencer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PSCA CAR-T CELLS
- Publication number 20220062338
- Publication date Mar 3, 2022
- BELLICUM PHARMACEUTICALS, INC.
- Paul WOODARD
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR ACTIVATING T CELLS USING AN INDUCIBLE CHIMERIC POLYPEPTIDE
- Publication number 20220025024
- Publication date Jan 27, 2022
- BELLICUM PHARMACEUTICS, INC.
- Aaron Edward Foster
- C07 - ORGANIC CHEMISTRY
Information Patent Application
T CELLS WITH SUICIDE SWITCH
- Publication number 20220002674
- Publication date Jan 6, 2022
- BELLICUM PHARMACEUTICALS, INC.
- Xiaoou Linnette Zhou
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYP...
- Publication number 20210346477
- Publication date Nov 11, 2021
- BELLICUM PHARMACEUTICALS, INC.
- David Spencer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS TO AUGMENT OR ALTER SIGNAL TRANSDUCTION
- Publication number 20210147507
- Publication date May 20, 2021
- BELLICUM PHARMACEUTICALS, INC.
- Joseph Henri Bayle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR ENHANCING AND MAINTAINING CAR-T CELL EFFICACY
- Publication number 20200347148
- Publication date Nov 5, 2020
- Bellicum Pharmaceuticals, Inc.
- Aaron Edward Foster
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYP...
- Publication number 20200237886
- Publication date Jul 30, 2020
- BELLICUM PHARMACEUTICALS, INC.
- David Spencer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES
- Publication number 20200230216
- Publication date Jul 23, 2020
- BELLICUM PHARMACEUTICALS, INC.
- Kevin Slawin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR CONTROLLING T CELL PROLIFERATION
- Publication number 20180265566
- Publication date Sep 20, 2018
- BELLICUM PHARMACEUTICALS, INC.
- David SPENCER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES
- Publication number 20180243384
- Publication date Aug 30, 2018
- BELLICUM PHARMACEUTICALS, INC.
- Kevin Slawin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
- Publication number 20170166877
- Publication date Jun 15, 2017
- BELLICUM PHARMACEUTICALS, INC.
- Joseph Henri BAYLE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS
- Publication number 20160175359
- Publication date Jun 23, 2016
- BELLICUM PHARMACEUTICALS, INC.
- David M. SPENCER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS
- Publication number 20160166613
- Publication date Jun 16, 2016
- BELLICUM PHARMACEUTICALS, INC.
- David M. SPENCER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES
- Publication number 20160151465
- Publication date Jun 2, 2016
- BELLICUM PHARMACEUTICALS, INC.
- Kevin SLAWIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYP...
- Publication number 20160058857
- Publication date Mar 3, 2016
- BELLICUM PHARMACEUTICALS, INC.
- David Spencer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR ACTIVATING T CELLS USING AN INDUCIBLE CHIMERIC POLYPEPTIDE
- Publication number 20160046700
- Publication date Feb 18, 2016
- BELLICUM PHARMACEUTICALS, INC.
- Aaron Edward Foster
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR CONTROLLING T CELL PROLIFERATION
- Publication number 20140286987
- Publication date Sep 25, 2014
- BELLICUM PHARMACEUTICALS, INC.
- David SPENCER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED GOLD NANOPARTICLES FOR THERAPY
- Publication number 20140086828
- Publication date Mar 27, 2014
- Aaron E. Foster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Aaron Edward FOSTER

Person

Patents Grantslast 30 patents

Methods for inducing partial apoptosis using caspase polypeptides

Modified T cell comprising a polynucleotide encoding an inducible s...

Costimulation of chimeric antigen receptors by MYD88 and CD40 polyp...

Costimulation of chimeric antigen receptors by MyD88 and CD40 polyp...

Methods for inducing partial apoptosis using caspase polypeptides

Methods for controlling T cell proliferation

Methods for inducing partial apoptosis using caspase polypeptides

Patents Applicationslast 30 patents

DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION

DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION

METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS

METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS

PSCA CAR-T CELLS

METHODS FOR ACTIVATING T CELLS USING AN INDUCIBLE CHIMERIC POLYPEPTIDE

T CELLS WITH SUICIDE SWITCH

COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYP...

METHODS TO AUGMENT OR ALTER SIGNAL TRANSDUCTION

METHODS FOR ENHANCING AND MAINTAINING CAR-T CELL EFFICACY

COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYP...

METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES

METHODS FOR CONTROLLING T CELL PROLIFERATION

METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES

DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION

METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS

METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS

METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES

COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYP...

METHODS FOR ACTIVATING T CELLS USING AN INDUCIBLE CHIMERIC POLYPEPTIDE

METHODS FOR CONTROLLING T CELL PROLIFERATION

MODIFIED GOLD NANOPARTICLES FOR THERAPY